Novel actions of HDL cholesterol: a potential new strategy for treatment of diabetes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

There are currently in excess of 170 million patients diagnosed with type 2 diabetes worldwide. Recent studies have identified novel actions of HDL cholesterol in relation to glucose and fat metabolism which provide a rationale for therapeutic approaches to raise levels of circulating HDL to manage the metabolic syndrome and type 2 diabetes. This research will investigate HDL signaling pathways and contribute significantly to our understanding of the metabolic actions of HDL in Humans.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2012

Funding Scheme: Early Career Fellowships

Funding Amount: $74,973.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biochemistry and Cell Biology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical studies | diabetes | exercise physiology | gene expression | muscle